Cargando…
Thirty-day hospital revisits after prostate brachytherapy: who is at risk?
BACKGROUND: Transperineal prostate brachytherapy is a common outpatient procedure for the treatment of prostate cancer. Whereas long-term morbidity and toxicities are widely published, rates of short-term complications leading to hospital revisits have not been well described. MATERIALS AND METHODS:...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Pacific Prostate Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664312/ https://www.ncbi.nlm.nih.gov/pubmed/31384608 http://dx.doi.org/10.1016/j.prnil.2018.03.003 |